01-10-2026 17:36 via drugs.com

GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria

THURSDAY, Oct. 1, 2026-- For adults with type 2 diabetes and moderate cardiovascular risk with albuminuria, glucagon-like peptide-1 (GLP-1) receptor agonists or sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduce the risk for deterioration...
Read more »

Pharmaceutical news



Nearly 1 in 10 Older Adults Used Cannabis in the Past Year
Cancer Survivors Have Lower Levels of Physical Activity
ACS: Aggregate Surgeon Supply Projected to Decline to 2038
Nearly 1 in 5 Patients Report Exposure to Ophthalmic Treatments Perceived as Bogus
Isometric Exercise Training Three Times a Week Preserves Cardiovascular Benefits
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
Exercise-Based Cardiac Rehab Beneficial for Coronary Heart Disease
Functional Decline Precedes Cardiovascular Disease Events by Many Years
EASD: Neurodiversity Prevalence Elevated for Those With Early Diagnosis of Type 2 Diabetes
Fifth Measles Death Reported As US Cases Reach New 35-Year High
Smiling At Babies Could Help Emotional Regulation Develop
Wall Sits Just Once A Week May Help Maintain Lower Blood Pressure
Wearable Wrist Device Could Boost Stroke Rehab
Odds Of Losing Your Nails, Hair Rise With GLP-1 Use
Desktop versie